Interventions of interest, July 2014 review:
- OnabotulinumtoxinA (Botox®, Allergan, Inc)
- Transcutaneous electrical nerve stimulation (Cefaly®, Cefaly Technology)
- Single pulse transcranial magnetic stimulation (SpringTMS™, eNeura Inc.)
Migraine is a common, recurrent headache disorder and is among the top ten causes of years lived with disability in the US. Someone experiencing a migraine episode may feel moderate-to-severe pain and other symptoms (e.g., nausea, vomiting, or sensitivity to light or to sound), have a reduced ability to function, or require bed rest. Despite its high prevalence and impairment, migraine is often not recognized or effectively treated.
For questions or additional information, please contact email@example.com.
Below you will find the final documents from the assessment review process: